Catalyst Wire Dossier Catalyst Wire Dossier

rAAV-GAD

recombinant adeno-associated virus-delivered glutamic acid decarboxylase · Neurologix, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for rAAV-GAD, covering 2012-02-22 to 2012-02-22. Get the full timeline:

Most recent: Clinical Trial Update: Long Term Follow-Up Study for rAAV-GAD Treated Subjects

See pricing